These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11195253)

  • 1. Canadian contingency plan for viral hemorrhagic fevers and other related diseases.
    Can Commun Dis Rep; 1997 Jan; 23 Suppl 1():i-iii, 1-13; i-iii, 1-13. PubMed ID: 11195253
    [No Abstract]   [Full Text] [Related]  

  • 2. Viral hemorrhagic fevers are often cited by the emerging infections and bioterrorism scientific communities. Introduction.
    Rollin PE
    Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E1-4; discussion E5. PubMed ID: 19751397
    [No Abstract]   [Full Text] [Related]  

  • 3. Viral haemorrhagic fevers with emphasis on Ebola virus disease and oro-dental healthcare.
    Samaranayake L; Scully C; Nair RG; Petti S
    Oral Dis; 2015 Jan; 21(1):1-6. PubMed ID: 25399654
    [No Abstract]   [Full Text] [Related]  

  • 4. Viral hemorrhagic fever: initial management of suspected and confirmed cases.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1983 Dec; 32 Suppl 2():27S-38S. PubMed ID: 6422225
    [No Abstract]   [Full Text] [Related]  

  • 5. [Viral hemorrhagic fevers: what is the risk for travelers?].
    Le Guenno B
    Med Trop (Mars); 1997; 57(4 Bis):511-3. PubMed ID: 9612763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lassa fever, Marburg and Ebola virus diseases and other exotic diseases: is there a risk to Canada?
    Clayton AJ
    Can Med Assoc J; 1979 Jan; 120(2):146-55. PubMed ID: 570088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for preventing the transmission of tuberculosis in Canadian Health Care Facilities and other institutional settings.
    Members of the Ad Hoc Committee for the Guidelines for Preventing the Transmission fo Tuberculosis in Canadian Health Care Facilities and Other Institutional Settings
    Can Commun Dis Rep; 1996 Apr; 22 Suppl 1():i-iv, 1-50, i-iv, 1-55. PubMed ID: 11195254
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of enhanced viral haemorrhagic fever surveillance on outbreak detection and response in Uganda.
    Shoemaker TR; Balinandi S; Tumusiime A; Nyakarahuka L; Lutwama J; Mbidde E; Kofman A; Klena JD; Ströher U; Rollin PE; Nichol ST
    Lancet Infect Dis; 2018 Apr; 18(4):373-375. PubMed ID: 29582758
    [No Abstract]   [Full Text] [Related]  

  • 9. [How to treat a patient with indications for an infectious viral hemorrhagic fever].
    Visser LG; Schippers EF; van den Broek PJ; Swaan CM
    Ned Tijdschr Geneeskd; 2003 Feb; 147(5):221-2. PubMed ID: 12645357
    [No Abstract]   [Full Text] [Related]  

  • 10. [Marburg, Lassa and Ebola viral hemorrhagic fevers (author's transl)].
    Ardouin C; Chevalier JM; Algayres JP
    Med Trop (Mars); 1981; 41(2):191-9. PubMed ID: 7242302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of the Canadian contingency plan for a case of suspected viral hemorrhagic fever.
    Loeb M; MacPherson D; Barton M; Olde J
    Infect Control Hosp Epidemiol; 2003 Apr; 24(4):280-3. PubMed ID: 12725358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating viral hemorrhagic fever.
    Mairuhu AT; Brandjes DP; van Gorp EC
    IDrugs; 2003 Nov; 6(11):1061-6. PubMed ID: 14600838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiology and prophylaxis of viral hemorrhagic fevers].
    Martet G; Coue JC; Lecamus JL
    Med Trop (Mars); 1990; 50(3):331-8. PubMed ID: 2263189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients infected with high-hazard viruses: scientific basis for infection control.
    Peters CJ; Jahrling PB; Khan AS
    Arch Virol Suppl; 1996; 11():141-68. PubMed ID: 8800796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebola hemorrhagic fever. A brief description.
    Can Commun Dis Rep; 1995 Jun; 21(11):103-4. PubMed ID: 7647744
    [No Abstract]   [Full Text] [Related]  

  • 16. [Viral hemorrhagic fevers--epidemiology and clinical picture].
    Zieliński A; Rosińska M; Gut W
    Przegl Epidemiol; 2003; 57(4):639-54. PubMed ID: 15029840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation precautions to prevent the spread of contagious diseases.
    Gould D
    Nurs Stand; 2009 Feb 4-10; 23(22):47-55; quiz 56. PubMed ID: 19263962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outbreaks of filovirus hemorrhagic fever: time to refocus on the patient.
    Bausch DG; Feldmann H; Geisbert TW; Bray M; Sprecher AG; Boumandouki P; Rollin PE; Roth C;
    J Infect Dis; 2007 Nov; 196 Suppl 2():S136-41. PubMed ID: 17940941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of viral haemorrhagic fevers in Switzerland.
    Hugonnet S; Sax H; Pittet D
    Euro Surveill; 2002 Mar; 7(3):42-4. PubMed ID: 12631944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How to treat a patient with indications for an infectious viral hemorrhagic fever].
    Visser LG; Schippers EF; Swaan CM; van den Broek PJ
    Ned Tijdschr Geneeskd; 2002 Nov; 146(46):2183-8. PubMed ID: 12467160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.